103 related articles for article (PubMed ID: 19740680)
1. Recurrent cardiac amyloidosis following previous heart transplantation.
Luk A; Ahn E; Lee A; Ross HJ; Butany J
Cardiovasc Pathol; 2010; 19(4):e129-33. PubMed ID: 19740680
[TBL] [Abstract][Full Text] [Related]
2. Cardiac transplantation using extended-donor criteria organs for systemic amyloidosis complicated by heart failure.
Maurer MS; Raina A; Hesdorffer C; Bijou R; Colombo P; Deng M; Drusin R; Haythe J; Horn E; Lee SH; Marboe C; Naka Y; Schulman L; Scully B; Shapiro P; Prager K; Radhakrishnan J; Restaino S; Mancini D
Transplantation; 2007 Mar; 83(5):539-45. PubMed ID: 17353770
[TBL] [Abstract][Full Text] [Related]
3. Successful intermediate-term outcome for patients with cardiac amyloidosis undergoing heart transplantation: results of a multicenter survey.
Hosenpud JD; Uretsky BF; Griffith BP; O'Connell JB; Olivari MT; Valantine HA
J Heart Transplant; 1990; 9(4):346-50. PubMed ID: 2398427
[TBL] [Abstract][Full Text] [Related]
4. Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.
Lacy MQ; Dispenzieri A; Hayman SR; Kumar S; Kyle RA; Rajkumar SV; Edwards BS; Rodeheffer RJ; Frantz RP; Kushwaha SS; Clavell AL; Dearani JA; Sundt TM; Daly RC; McGregor CG; Gastineau DA; Litzow MR; Gertz MA
J Heart Lung Transplant; 2008 Aug; 27(8):823-9. PubMed ID: 18656793
[TBL] [Abstract][Full Text] [Related]
5. Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation.
Leung N; Dispenzieri A; Lacy MQ; Kumar SK; Hayman SR; Fervenza FC; Cha SS; Gertz MA
Clin J Am Soc Nephrol; 2007 May; 2(3):440-4. PubMed ID: 17699449
[TBL] [Abstract][Full Text] [Related]
6. High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.
Perz JB; Schonland SO; Hundemer M; Kristen AV; Dengler TJ; Zeier M; Linke RP; Ho AD; Goldschmidt H
Br J Haematol; 2004 Dec; 127(5):543-51. PubMed ID: 15566357
[TBL] [Abstract][Full Text] [Related]
7. Heart transplantation and cardiac amyloidosis: approach to screening and novel management strategies.
Varr BC; Liedtke M; Arai S; Lafayette RA; Schrier SL; Witteles RM
J Heart Lung Transplant; 2012 Mar; 31(3):325-31. PubMed ID: 22051505
[TBL] [Abstract][Full Text] [Related]
8. Heart transplantation for cardiac amyloidosis: successful one-year outcome despite recurrence of the disease.
Conner R; Hosenpud JD; Norman DJ; Pantely GA; Cobanoglu A; Starr A
J Heart Transplant; 1988; 7(2):165-7. PubMed ID: 3284989
[TBL] [Abstract][Full Text] [Related]
9. Orthotopic liver transplantation for hereditary fibrinogen amyloidosis.
Zeldenrust S; Gertz M; Uemichi T; Björnsson J; Wiesner R; Schwab T; Benson M
Transplantation; 2003 Feb; 75(4):560-1. PubMed ID: 12605128
[TBL] [Abstract][Full Text] [Related]
10. Successful heart transplantation following melphalan plus dexamethasone therapy in systemic AL amyloidosis.
Mignot A; Bridoux F; Thierry A; Varnous S; Pujo M; Delcourt A; Gombert JM; Goujon JM; Favreau F; Touchard G; Herpin D; Jaccard A
Haematologica; 2008 Mar; 93(3):e32-5. PubMed ID: 18310532
[TBL] [Abstract][Full Text] [Related]
11. Regression of cardiac amyloid after autologous stem-cell transplantation.
Blair JE; Zeigler SM; Mehta J; Singhal S; Cotts W
J Heart Lung Transplant; 2009 Jul; 28(7):746-8. PubMed ID: 19560707
[TBL] [Abstract][Full Text] [Related]
12. Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation.
Liepnieks JJ; Benson MD
Amyloid; 2007 Dec; 14(4):277-82. PubMed ID: 17968687
[TBL] [Abstract][Full Text] [Related]
13. Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity.
Worel N; Schulenburg A; Mitterbauer M; Keil F; Rabitsch W; Kalhs P; Gisslinger H; Raderer M; Geissler K; Höcker P; Zielinski CC; Oberbauer R; Greinix HT
Wien Klin Wochenschr; 2006 Feb; 118(1-2):49-53. PubMed ID: 16489526
[TBL] [Abstract][Full Text] [Related]
14. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients.
Terpos E; Apperley JF; Samson D; Giles C; Crawley C; Kanfer E; Olavarria E; Goldman JM; Rahemtulla A
Bone Marrow Transplant; 2003 Feb; 31(3):163-70. PubMed ID: 12621476
[TBL] [Abstract][Full Text] [Related]
15. Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey.
Hosenpud JD; DeMarco T; Frazier OH; Griffith BP; Uretsky BF; Menkis AH; O'Connell JB; Olivari MT; Valantine HA
Circulation; 1991 Nov; 84(5 Suppl):III338-43. PubMed ID: 1934428
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of lattice corneal dystrophy caused by incomplete removal of stroma after deep lamellar keratoplasty.
Yao YF; Jin YQ; Zhang B; Zhou P; Zhang YM; Qiu WY; Mou SL; Wu LQ
Cornea; 2006 Dec; 25(10 Suppl 1):S41-6. PubMed ID: 17001192
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal perforation early after peripheral blood stem cell transplantation for AL amyloidosis.
Schulenburg A; Kalhs P; Oberhuber G; Reiter E; Base W; Greinix HT
Bone Marrow Transplant; 1998 Aug; 22(3):293-5. PubMed ID: 9720746
[TBL] [Abstract][Full Text] [Related]
18. Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial.
Cohen AD; Zhou P; Chou J; Teruya-Feldstein J; Reich L; Hassoun H; Levine B; Filippa DA; Riedel E; Kewalramani T; Stubblefield MD; Fleisher M; Nimer S; Comenzo RL
Br J Haematol; 2007 Oct; 139(2):224-33. PubMed ID: 17897298
[TBL] [Abstract][Full Text] [Related]
19. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
